Human T-Lymphotropic Virus Type 1
CD8+ cells are major determinant of HTLV-1 proviral load
Published in AIDS Weekly, July 4th, 2005
"The CD8+ lymphocyte response is a main component of host immunity, yet it is difficult to quantify its contribution to the control of persistent viruses.
"Consequently, it remains controversial as to whether CD8+ cells have a biologically significant impact on viral burden and disease progression in infections such as human immunodeficiency virus-1 and human T-lymphotropic virus type 1 (HTLV-1)," scientists in England report.
"Experiments to ascertain the impact of CD8+ cells on viral burden based on CD8+ cell frequency or specificity alone give inconsistent results....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-07-04)
More Articles from AIDS Weekly
- HIV/AIDS Pathogenesis
Nonreplicating HIV-1 contributes to T cell depletion by activating CD4/CD8 cells - HIV/AIDS Prevention
Emergency departments used as public health programs for HIV-risk populations - HIV/AIDS Prognosis
High plasma suPAR independent predictor of mortality in HIV-1-infected patients - HIV/AIDS Research
Mouse model generates HIV specific human humoral and cellular immune response - Aging
CD8+ T-cell replicative senescence modulates age-related pathologies - Blood Safety
Unsafe injection practices still occur in rural North India health settings - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
